Our Team Archive - Page 2 of 17

Angela Belcher, PhD, Lan Coffman, MD, PhD & Kripa K. Varanasi, PhD

Project Title: “Investigating Physico-Chemical Properties of Mesenchymal Stromal Cells as Biophysical Markers for Early Detection of Ovarian Cancers”

Dr. Belcher is the James Mason Crafts Professor of Biological Engineering, Materials Science and the Koch Institute for Integrative Cancer Research at MIT and the head of the Department of Biological Engineering at MIT. Dr. Coffman is an Assistant Professor at the University of Pittsburgh with dual appointments in the Department of Medicine, Division of Hematology/Oncology and Division of Gynecologic Oncology. Dr. Varanasi is a Professor in the Department of Mechanical Engineering at MIT.

Gottfried Konecny, MD & Jillian Phallen, PhD

Project Title: “Cell-free DNA fragmentomes and protein biomarkers for early detection of ovarian cancer: Discovering biology, creating improved classifiers, and establishing logistics for clinical trial to validate liquid biopsy multi-analyte test for ovarian cancer screening”

Dr. Konecny is a Professor of Oncology and Obstetrics and Gynecology, and the Director of Medical Gynecologic Oncology at UCLA. Dr. Phallen is an Assistant Professor of Oncology at Johns Hopkins University School of Medicine.

Andrew K. Godwin, PhD & Steven Soper, PhD

Project Title: Liquid Biopsy Using Tumor Specific Extracellular Vesicles for the Early Detection of Epithelial Ovarian Cancer

Dr. Godwin is the Chancellors Distinguished Chair in Biomedical Sciences, Endowed Professor, and Director of Molecular Oncology, Pathology and Laboratory Medicine at The University of Kansas Medical Center. In the fall of 2019, Dr. Godwin was named the recipient of the Dolph Simons Award in the Biomedical Sciences. Dr. Soper is a Foundation Distinguished Professor at The University of Kansas and holds joint appointments in the Departments of Chemistry and Mechanical Engineering.

About Team Science Grants

The Tina’s Wish Team Science Grant (formerly the Individual Investigator Grant) encourages collaboration in pursuit of an effective screen for the early detection or a prevention strategy for ovarian cancer. The Team Science Grant is $500,000 over two (2) years.

Janiya Wade

Janiya brings a unique perspective to Tina’s Wish through her background in event planning and marketing national touring Broadway shows for three years. She graduated from Ramapo College of NJ with an MBA in Marketing and is committed to utilizing her skills to advance women’s health. She is excited to be part of Tina’s Wish and is dedicated to making a meaningful impact.

Amit M. Oza, MD

Dr. Oza has been PI and co-investigator in >150 phase I, II and III trials for gynecological cancer and advanced colorectal malignancies. Dr. Oza is Head of the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre, Co-chair of the UHN Clinical Research Collaborative Center, Past-Chair of the International Gynecologic Cancer InterGroup (GCIG), Chair of the GCIG Scientific Committee, Co-Chair of the Clinical Research Executive at UHN, and past co-chair of the National Cancer Institute Gynecologic Caner Steering Committee. Under his direction, the gynecology group is one of the largest ovarian cancer (OC) clinical trials groups consistently accruing >30% of all patients seen onto clinical trials (>200/yr) at PM. The group has participated or led seminal studies in gynecologic cancers that have led to the approval or use of targeted agents such as PARP inhibitors (olaparib, niraparib) and anti-angiogenic agents (bevacizumab) internationally.

Over the last decade, he has been PI/co-PI of 19 grants from agencies such as the Canadian Cancer Society Research Institute, Canadian Institutes for Health Research, National Institutes of Health (NIH), Ontario Institute for Cancer Research, and the US Department of Defense. Over his career he has published >315 articles (all types) including Clinical Cancer Research (IF=10), JAMA Oncology (IF=20), New England Journal of Medicine (IF=79), Lancet Oncology (IF=36) and an invited seminar to CA: A Cancer Journal for Clinicians (IF=24).

Enter your keyword

Archives